Abstract |
Poxvirus-vectors have been widely used in vaccine development for several important human and animal diseases; some of these vaccines have been licensed and used extensively. Swinepox virus (SPV) is well suited to develop recombinant vaccines because of its large packaging capacity for recombinant DNA, its host range specificity, and its ability to induce appropriate immune responses.
|
Authors | Hong-Jie Fan, Hui-Xing Lin |
Journal | Methods in molecular biology (Clifton, N.J.)
(Methods Mol Biol)
Vol. 1349
Pg. 163-75
( 2016)
ISSN: 1940-6029 [Electronic] United States |
PMID | 26458836
(Publication Type: Journal Article)
|
Chemical References |
- DNA, Recombinant
- Vaccines, Synthetic
|
Topics |
- Animals
- DNA, Recombinant
(genetics, immunology)
- Genetic Vectors
- Humans
- Suipoxvirus
(genetics, immunology)
- Vaccination
(methods, veterinary)
- Vaccines, Synthetic
(biosynthesis, genetics)
|